AWH Aspira Women's Health Inc. Stock Quote

publish chart | save to portfolio | create alert

Settings

AWH [NASD]

Aspira Women's Health Inc.

Healthcare | Diagnostics & Research | USA

statements

Index	-	P/E	-	EPS (ttm)	-0.15	Insider Own	1.50%	Shs Outstand	103.20M	Perf Week	9.63%
Market Cap	498.70M	Forward P/E	-	EPS next Y	-0.17	Insider Trans	142.86%	Shs Float	51.13M	Perf Month	26.12%
Income	-15.20M	PEG	-	EPS next Q	-0.04	Inst Own	28.90%	Short Float	22.25%	Perf Quarter	62.59%
Sales	4.50M	P/S	110.82	EPS this Y	-8.50%	Inst Trans	6.13%	Short Ratio	16.15	Perf Half Y	44.85%
Book/sh	0.14	P/B	34.14	EPS next Y	-13.30%	ROA	-103.90%	Target Price	-	Perf Year	529.03%
Cash/sh	0.18	P/C	26.53	EPS next 5Y	-	ROE	-169.70%	52W Range	0.53 - 5.78	Perf YTD	490.12%
Dividend	-	P/FCF	-	EPS past 5Y	19.90%	ROI	-152.80%	52W High	-17.30%	Beta	3.08
Dividend %	-	Quick Ratio	4.40	Sales past 5Y	12.50%	Gross Margin	33.70%	52W Low	800.19%	ATR	0.28
Employees	52	Current Ratio	4.40	Sales Q/Q	-7.70%	Oper. Margin	-	RSI (14)	64.95	Volatility	6.05% 6.60%
Optionable	Yes	Debt/Eq	0.15	EPS Q/Q	-5.60%	Profit Margin	-	Rel Volume	0.62	Prev Close	4.80
Shortable	Yes	LT Debt/Eq	0.12	Earnings	Nov 12 AMC	Payout	-	Avg Volume	704.48K	Price	4.78
Recom	1.50	SMA20	6.48%	SMA50	26.66%	SMA200	65.56%	Volume	435,060	Change	-0.42%

Oct-30-20

Initiated

William Blair

Outperform

Nov-29-20 08:24PM	Is Aspira Womens Health Inc. (AWH) A Good Stock To Buy? Insider Monkey
Nov-19-20 08:00AM	Aspira Womens Health, Inc. Announces a Collaborative Agreement with Baylor Genetics for the Co-Development of an Ovarian Cancer Early-Detection Test GlobeNewswire
Nov-14-20 07:24AM	Does Aspira Women's Health (NASDAQ:AWH) Have A Healthy Balance Sheet? Simply Wall St.
Nov-12-20 04:01PM	Aspira Womens Health Reports Third Quarter 2020 Financial Results GlobeNewswire
02:30PM	Aspira Women's Health, Inc. to Host Earnings Call ACCESSWIRE
Nov-10-20 08:30AM	Aspira Womens Health, Inc. Strengthens Executive Leadership with New Appointments GlobeNewswire
Nov-09-20 08:00AM	Aspira Womens Health Strengthens Board of Directors with the Addition of Dr. Sandra E. Brooks GlobeNewswire
Nov-05-20 08:00AM	Aspira Womens Health, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum GlobeNewswire
Nov-04-20 08:00AM	Aspira Womens Health, Inc. to Report Third Quarter 2020 Financial Results on November 12th GlobeNewswire +6.06%
Oct-28-20 08:00AM	Aspira Womens Health Addresses Clinical Disparities in Ovarian Cancer Risk Assessment with OVA1plus Across Racial Profiles News Direct -8.26%
Oct-14-20 08:00AM	Aspira Womens Health Inc. Announces it is now an Anthem BlueCross BlueShield of Georgia Participating Provider GlobeNewswire
Oct-09-20 08:00AM	Aspira Womens Health, Inc. to Present at MicroCap Rodeo Best Ideas Bowl October 13-16 GlobeNewswire
Oct-08-20 03:30PM	The MicroCap Rodeo Best Ideas Bowl 2020; October 13-16, 2020 ACCESSWIRE
Oct-06-20 07:57AM	Key Things To Understand About Aspira Women's Health's (NASDAQ:AWH) CEO Pay Cheque Simply Wall St.
Sep-28-20 08:30AM	Aspira Womens Health has Emerged as a Global Leader for Innovations in Ovarian Cancer Risk Assessment Starting with OVA1®plus, OVANex, OVAInherit and ASPiRA GenetiX News Direct
Sep-15-20 05:01PM	Aspira Womens Health, Inc. to Host Key Opinion Leader Call on Ovarian Cancer Diagnostics, Innovation Pipeline, and Rebranding Initiatives GlobeNewswire
Sep-08-20 11:44AM	Aspira Womens Health, Inc. to Present at Cantor Virtual Healthcare Conference GlobeNewswire
Aug-22-20 10:01AM	Is Aspira Women's Health Inc. (NASDAQ:AWH) Popular Amongst Insiders? Simply Wall St.
Aug-14-20 03:51PM	UPDATE Aspira Womens Health Reports Second Quarter 2020 Financial Results GlobeNewswire -22.22%
Aug-13-20 04:01PM	Aspira Womens Health Reports Second Quarter 2020 Financial Results GlobeNewswire
Jul-31-20 09:23AM	Aspira Womens Health, Inc. to Report Second Quarter 2020 Financial Results on August 13th GlobeNewswire
Jul-08-20 06:30AM	Insider Buying: Jack Schuler Just Spent US$8.0m On Aspira Women's Health Inc. (NASDAQ:AWH) Shares Simply Wall St.
Jul-01-20 11:23AM	Aspira Womens Health Inc. Announces Equity Financing of Approximately $11 Million GlobeNewswire
Jun-29-20 08:00AM	Aspira Womens Health, Inc. Announces First Patient Enrolled in Prospective OVANex Study for Benign Pelvic Mass Monitoring GlobeNewswire -21.71%

Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. The company provides sells OVA1, Overa, and Ova1PLUS risk of malignancy tests for ovarian cancer. It also offers ASPiRA GenetiX, a genetic test for specific women's health diseases. In addition, the company owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, it is developing diagnostic algorithms, as well as a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer. Aspira Women's Health Inc. has entered into a collaborative research agreement with Baylor Genetics to co-develop a novel ovarian cancer early-detection test. It serves physicians, physician office laboratories, and hospital laboratories. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was founded in 1993 and is headquartered in Austin, Texas.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SCHREIBER DAVID	Director	Sep 08	Sale	2.78	50,000	139,000	185,018	Sep 10 05:35 PM
SCHULER JACK W	10% Owner	Jul 01	Buy	3.50	2,285,715	8,000,003	25,394,517	Jul 06 05:25 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience